Prenatal and newborn genetic testing is referred to as the utilization of screening or diagnostic procedures for a fetus or a new born baby to detect chromosomal abnormalities such as Down syndrome, Patau syndrome and Edward syndrome. Prenatal testing and diagnosis have enabled the detection of certain genetic abnormalities in as early as 8 to 10 weeks of gestation and also helps to determine the sex of the fetus. Genetic testing is broadly segmented as newborn screening, diagnostic testing, carrier testing, prenatal testing, preimplantation testing, predictive and forensic testing. Higher maternal age and associated late pregnancies, public awareness about genetic disorders, and technological advancements are some of the factors contributing to the growth of global prenatal and newborn genetic testing market. Diagnostic methods are more effective, accurate and a preferred option for the detection of chromosome abnormalities as compared to the screening methods.
The global prenatal and newborn genetic testing market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).
The global prenatal and newborn genetic testing market segmentation is based on technologies (prenatal and newborn genetic diagnostic techniques, array-comparative genomic hybridization, fluorescence in-situ hybridization, polymerase chain reaction, prenatal and newborn genetic screening methods, maternal serum screening, non-invasive prenatal tests such as MaterniT21 PLUS, Verifi, Harmony, Panorama, NIFTY, PrenaTest and Bambni Test).
The global prenatal and newborn genetic testing market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global prenatal and newborn genetic testing market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major players operating in the global prenatal and newborn genetic testing market and included in this report are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Natera, Inc. and Illumina, Inc.